The WTO and India's pharmaceuticals industry : patent protection, TRIPS, and developing countries

著者

書誌事項

The WTO and India's pharmaceuticals industry : patent protection, TRIPS, and developing countries

Sudip Chaudhuri

Oxford University Press, 2005

大学図書館所蔵 件 / 全12件

この図書・雑誌をさがす

注記

Includes bibliographical references (p. [326]-348) and index

内容説明・目次

内容説明

The establishment of the World Trade Organization (WTO) in 1995 brought about significant changes in international economic relations between countries. To comply with the Trade Related Aspects of Intellectual Property Rights (TRIPS) Agreement of the WTO, India introduced product patent protection in pharmaceuticals from January 2005. TRIPS has generated a huge controversy in India and abroad. India has emerged as a major source of low-cost, quality drugs for the entire world and thus plays an important role. While there are a large number of pharmaceutical manufacturers in the world, only a handful of multinationals dominate the industry. By using patent rights, multinational companies prevednted developing countries like India from realizing their potential of industrial growth and drug prices were among the highest in the world. The book analyses: BL the remarkable growth of the Indian pharmaceutical industry since the early 1970s when product patent protection in pharmaceu ticals was abolished BL whether the claimed benefits for developing countries, under TRIPS, have materialized BL what can be done, if as apprehended, the prices of patent protected drugs rise BL whether, and to what extent, developing countries have been able to use the provisions and the flexibilities promised under TRIPS The volume will be of interest not only to academics but also to policymakers, pharma companies, business analysts, students, NGOs, and others interested in the impact of globalization under WTO.

目次

  • INTRODUCTION
  • NATIONAL PATENTS, INDUSTRIAL POLICY, AND RISE AND GROWTH OF THE PHARMACEUTICAL INDUSTRY IN INDIA
  • GLOBALIZATION OF PATENT LAWS: FLEXIBILITIES UNDER TRIPS AND CHANGES IN PHARMACEUTICAL PATENTS IN INDIA
  • PATENT REGIME AND ROLE OF MNCS IN THE PHARMACEUTICAL INDUSTRY IN INDIA
  • TRIPS AND R&D FOR NEGLECTED DISEASES
  • GROWTH AND PROSPECTS OF GENERIC PHARMACEUTICAL EXPORTS FROM INDIA
  • TRIPS AND AFFORDABILITY AND ACCESSIBILITY OF PHARMACEUTICAL PRODUCTS
  • DRUG PRICE CONTROL: INDIA'S EXPERIENCE AND FUTURE PROSPECTS
  • SHOULD DEVELOPING COUNTRIES PROVIDE PATENT PROTECTION IN PHARMACEUTICAL PRODUCTS?
  • BIBLIOGRAPHY
  • INDEX

「Nielsen BookData」 より

詳細情報

ページトップへ